MicroRNA profiling in canine multicentric lymphoma.

Lymphoma is the most common hematopoietic tumour in dogs and is remarkably similar to the human disease. Tumour biomarker discovery is providing new tools for diagnostics and predicting therapeutic response and clinical outcome. MicroRNAs are small non-coding RNAs that participate in post-transcript...

Full description

Bibliographic Details
Main Authors: Karlee K L Craig, Geoffrey A Wood, Stefan M Keller, Anthony J Mutsaers, R Darren Wood
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0226357
_version_ 1819259625832185856
author Karlee K L Craig
Geoffrey A Wood
Stefan M Keller
Anthony J Mutsaers
R Darren Wood
author_facet Karlee K L Craig
Geoffrey A Wood
Stefan M Keller
Anthony J Mutsaers
R Darren Wood
author_sort Karlee K L Craig
collection DOAJ
description Lymphoma is the most common hematopoietic tumour in dogs and is remarkably similar to the human disease. Tumour biomarker discovery is providing new tools for diagnostics and predicting therapeutic response and clinical outcome. MicroRNAs are small non-coding RNAs that participate in post-transcriptional gene regulation and their aberrant expression can impact genes involved in cancer. The aim of this study was to characterize microRNA expression in lymph nodes and plasma from dogs with multicentric B or T cell lymphoma compared to healthy control dogs. We further compared expression between lymph nodes and corresponding plasma samples and assessed changes in expression at relapse compared to time of diagnosis. Lastly, we investigated microRNAs for association with clinical outcome in patients treated with CHOP chemotherapy. A customized PCR array was utilized to profile 38 canine target microRNAs. Quantification was performed using real time RT-qPCR and relative expression was determined by the delta-delta Ct method. In lymph nodes, there were 16 microRNAs with significantly altered expression for B cell lymphoma and 9 for T cell lymphoma. In plasma, there were 15 microRNAs altered for B cell lymphoma and 3 for T cell lymphoma. The majority of microRNAs did not have correlated expression between lymph node and plasma and only 8 microRNAs were significantly different between diagnosis and relapse. For B cell lymphoma, 8 microRNAs had differential expression in the non-remission group compared to dogs that completed CHOP in complete remission. Four of these microRNAs were also altered in patients that died prior to one-year. Kaplan-Meier survival curves for high versus low microRNA expression revealed that 10 microRNAs were correlated with progression-free survival and 3 with overall survival. This study highlights microRNAs of interest for canine multicentric lymphoma. Future goals include development of microRNA panels that may be useful as biomarkers with the intent to provide improved outcome prediction to veterinary cancer patients.
first_indexed 2024-12-23T19:13:00Z
format Article
id doaj.art-16e842bbbbb74ae59641dca85b73371d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T19:13:00Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-16e842bbbbb74ae59641dca85b73371d2022-12-21T17:34:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011412e022635710.1371/journal.pone.0226357MicroRNA profiling in canine multicentric lymphoma.Karlee K L CraigGeoffrey A WoodStefan M KellerAnthony J MutsaersR Darren WoodLymphoma is the most common hematopoietic tumour in dogs and is remarkably similar to the human disease. Tumour biomarker discovery is providing new tools for diagnostics and predicting therapeutic response and clinical outcome. MicroRNAs are small non-coding RNAs that participate in post-transcriptional gene regulation and their aberrant expression can impact genes involved in cancer. The aim of this study was to characterize microRNA expression in lymph nodes and plasma from dogs with multicentric B or T cell lymphoma compared to healthy control dogs. We further compared expression between lymph nodes and corresponding plasma samples and assessed changes in expression at relapse compared to time of diagnosis. Lastly, we investigated microRNAs for association with clinical outcome in patients treated with CHOP chemotherapy. A customized PCR array was utilized to profile 38 canine target microRNAs. Quantification was performed using real time RT-qPCR and relative expression was determined by the delta-delta Ct method. In lymph nodes, there were 16 microRNAs with significantly altered expression for B cell lymphoma and 9 for T cell lymphoma. In plasma, there were 15 microRNAs altered for B cell lymphoma and 3 for T cell lymphoma. The majority of microRNAs did not have correlated expression between lymph node and plasma and only 8 microRNAs were significantly different between diagnosis and relapse. For B cell lymphoma, 8 microRNAs had differential expression in the non-remission group compared to dogs that completed CHOP in complete remission. Four of these microRNAs were also altered in patients that died prior to one-year. Kaplan-Meier survival curves for high versus low microRNA expression revealed that 10 microRNAs were correlated with progression-free survival and 3 with overall survival. This study highlights microRNAs of interest for canine multicentric lymphoma. Future goals include development of microRNA panels that may be useful as biomarkers with the intent to provide improved outcome prediction to veterinary cancer patients.https://doi.org/10.1371/journal.pone.0226357
spellingShingle Karlee K L Craig
Geoffrey A Wood
Stefan M Keller
Anthony J Mutsaers
R Darren Wood
MicroRNA profiling in canine multicentric lymphoma.
PLoS ONE
title MicroRNA profiling in canine multicentric lymphoma.
title_full MicroRNA profiling in canine multicentric lymphoma.
title_fullStr MicroRNA profiling in canine multicentric lymphoma.
title_full_unstemmed MicroRNA profiling in canine multicentric lymphoma.
title_short MicroRNA profiling in canine multicentric lymphoma.
title_sort microrna profiling in canine multicentric lymphoma
url https://doi.org/10.1371/journal.pone.0226357
work_keys_str_mv AT karleeklcraig micrornaprofilingincaninemulticentriclymphoma
AT geoffreyawood micrornaprofilingincaninemulticentriclymphoma
AT stefanmkeller micrornaprofilingincaninemulticentriclymphoma
AT anthonyjmutsaers micrornaprofilingincaninemulticentriclymphoma
AT rdarrenwood micrornaprofilingincaninemulticentriclymphoma